Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: March 1, 2012
Last updated: August 16, 2016
Last verified: August 2016